No evidence of increased risk of acquired rifampin resistance

CMAJ. 2019 Nov 25;191(47):E1314-E1315. doi: 10.1503/cmaj.73353.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Isoniazid
  • Latent Tuberculosis*
  • Mycobacterium tuberculosis*
  • Rifampin

Substances

  • Isoniazid
  • Rifampin